Tenet’s 2012 Adjusted EBITDA Could Reach $1.3B

Dallas-based Tenet Healthcare expects its 2012 adjusted earnings before interest, taxes, depreciation and amortization to total between $1.2 billion and $1.3 billion, according to a Tenet (pdf) news release.

Advertisement

The 2012 adjusted EBITDA range includes deferred income of some Medicare health IT incentive payments, according to the news release.

Tenet will release fourth quarter and total 2011 financial results on Feb. 28.

Related Articles on Tenet Healthcare:

5 For-Profit Hospital Chains Begin Year With Falling Stock Prices

Tenet Healthcare Names Britt T. Reynolds President of Hospital Operations

Tenet’s 3Q Profit Plummets Due to Tax Benefits Associated With Loss Carryforward

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Financial Management

Advertisement

Comments are closed.